It's time to take time off and do something else.
It's tax time, it's freezing cold and winter here in OZ.
The sharemarket is still struggling and trying to come up for air after a minimum 27% drop (and more) and the worst in 20 or some say 60 years. The US recession is virtually admitted and should now be on the way to recovery except for the price of oil. Since we elected a new labour government in September, housing mortgage interest has risen , there's a crisis in home sales and rental properties and a big drop in new housing applications. Mortgages are up, food prices are up and transport.
There is gloom and doom everywhere. I still think there are signs of recovery and that by the end of the year everything should be improved.
The main thing is to hang in there, don't sell and take unnecessary losses, just hibernate for a while! Make yourself a watch list on yahoo finance and get Yahoo to send alerts to your email when a stock goes up by 10% and ignore the downs. Don't ask for an alert when a stock goes down. You don't need the stress.
BUY - Bounty OIl is holding at a cheap price around 6 cents so is LKO lakelands Oil and Gas at less than 2 cents.
Whatever stock you look at is at a record low price and there are bargains everywhere.
Buy and hold and the day will come when you will be saying that you were so clever to buy so cheap. Just don't borrow, and be conservative.
Sell only when you see a profit of 25%.
and I'm sure you will.
Give it time, and the gloom and doom will go. Life goes on.
Remember we are not financial advisors..
Sampson management Services (SMS) educate and inform only...We are Assett Management Consultants- we teach you about risk and how to measure that risk according to the international standards on Quality, Environment, OHS, and Risk management in an integrated approach.
Ref standards:
AS/NZS/ISO 9001, AS/NZS/ISO 14001, AS/NZS/ISO 4804, AS/NZS/ISO 4360.
Megamoneybox address is http://Megamoneybox.blogspot.com.au We try to help you earn money on the internet.We give free share trading tips. We aim to educate and enthuse. We are in Australia in the land of the Sun. We are asset management and risk consultants, are not financial advisors. You Trade at your own risk. We could be wrong. So do your homework. Go to our other blogs to de stress. We are not big risk takers. We asses, investigate, analyse and then decide.
Friday, July 11, 2008
Friday, May 30, 2008
Todays tip JRV Jervois
google9a9be4a759db7f0e.htmlhere's a free share market tip
JRV -Jervois mining ( Petrol) have a trading halt and many holders are hoping for a JV- Joint venture or an important announcement.. won't know till next week..June 3rd, but some are guessing a chinese JV or a takeover..
and at .02cents -- we'll all be celebrating.. would even be cheap at .03cents
especially if we bought and held through all this volatility!
Here's cheers! Mega
JRV -Jervois mining ( Petrol) have a trading halt and many holders are hoping for a JV- Joint venture or an important announcement.. won't know till next week..June 3rd, but some are guessing a chinese JV or a takeover..
and at .02cents -- we'll all be celebrating.. would even be cheap at .03cents
especially if we bought and held through all this volatility!
Here's cheers! Mega
Thursday, May 22, 2008
HAW might GET YOU SMILING HAW ..HAW..
HAW- HAWTHORN RESOURCES was GNL- gold prospectors are rising.. at less than .03 cents buy now -- it looks as if it could be big.
GO TO http://www.asx.com.au/ and check the price Educate yourself by reading the recent announcements.
Remember we are not financial advisors.. Sampson management Services (SMS) educate and inform only...
We trade as Assett Management Consultants- we teach you about risk and how to
measure that risk according to the international standards on Quality, Environment, OHS, and Risk management in an integrated approach.
Ref standards AS/NZS/ISO 90o1, AS/NZS/ISOISO 14001, AS/NZS/ISO4804, AS/NZS/ISO 4360.
GO TO http://www.asx.com.au/ and check the price Educate yourself by reading the recent announcements.
Remember we are not financial advisors.. Sampson management Services (SMS) educate and inform only...
We trade as Assett Management Consultants- we teach you about risk and how to
measure that risk according to the international standards on Quality, Environment, OHS, and Risk management in an integrated approach.
Ref standards AS/NZS/ISO 90o1, AS/NZS/ISOISO 14001, AS/NZS/ISO4804, AS/NZS/ISO 4360.
Sunday, May 18, 2008
another good resource
Mega posts on the http://asxinsider.informe.com and you can reply and add your own "sixpence worth". go there to read MTNEWS- US stock news and also to see past opinions on various stocks.
It's FREE.
Mega posted there about CVI Cityview- and Pussycat replied, but since then we made some money on CVI.
We bought below 10c and now it is over 20c.
It's all worth investigating.
It's FREE.
Mega posted there about CVI Cityview- and Pussycat replied, but since then we made some money on CVI.
We bought below 10c and now it is over 20c.
It's all worth investigating.
a couple of tips today
Yellow rock resources YRR jumped 40% over the last week. now .18c read ann on the asx -
GPN own 21% in them.. and GPN is much cheaper at about .012c , but Yellow rock are the big players.
you could buy about 50,000 shares in GPN for only 600.00 plus the brokerage fees!!!
also Indophil resources IRN were up 43% last week with an xstrata bid, and today Lion investments are urging shareholders to refuse it... there is some action here..
Look them up on www.asx.com.au type in the code and view their announcements.
That's how you learn what it all means ..
Another "yellow" is Deep Yellow DYL seems on the rise.. ?
Mega
GPN own 21% in them.. and GPN is much cheaper at about .012c , but Yellow rock are the big players.
you could buy about 50,000 shares in GPN for only 600.00 plus the brokerage fees!!!
also Indophil resources IRN were up 43% last week with an xstrata bid, and today Lion investments are urging shareholders to refuse it... there is some action here..
Look them up on www.asx.com.au type in the code and view their announcements.
That's how you learn what it all means ..
Another "yellow" is Deep Yellow DYL seems on the rise.. ?
Mega
Tuesday, May 6, 2008
today's Free Hot tip
Today's FREE educational HOT Tip (we also published this on the NEW Chinese - Australian relationship and networking webpage called Bguanxi. GCN.ax Go Connect, have instituted this new free webpage/blogsite. go to http://www.bguanxi.com/ our page there is called www.bguanxi.com/megamoneybox.html
GCN.ax is worth investing in because they are innovative and forward thinking. Esablishing business links with China is important GCN are below 10 cents. We'll blog about GCN later.
Here's today's Hot tip
As you all know, the resource sector is still the place to invest.
At http://www.megamoneybox.com/ we believe any exploration and effort for renewable energy will be rewarded, because climate change and the cost of energy are the driving forces.
Our tip, which we identified on 27.11.07 was CXY.ax. At that time we paid .082 cents, and during the recent downturn in the market it fell along with other stocks. BUT now it is rising again, currently at about .085 and still under ten cents,
"Mega" sees THIS as a great opportunity. Buy and hold for at least 6 months.
One of our researched articles talks about the bigger players but includes CXY.ax Cougar energy at the bottom of the article.
When you subscribe to Megamoneybox monthly newsletter we will send you a portion of our research on the topic.
Always do your own research on any hot tips. look for CXY.ax Cougar energy - on the Australian stock exchange.
Simply go to http://www.asx.com.au/ type in the code cxy and Cougar Energy page will come up.
GCN.ax is worth investing in because they are innovative and forward thinking. Esablishing business links with China is important GCN are below 10 cents. We'll blog about GCN later.
Here's today's Hot tip
As you all know, the resource sector is still the place to invest.
At http://www.megamoneybox.com/ we believe any exploration and effort for renewable energy will be rewarded, because climate change and the cost of energy are the driving forces.
Our tip, which we identified on 27.11.07 was CXY.ax. At that time we paid .082 cents, and during the recent downturn in the market it fell along with other stocks. BUT now it is rising again, currently at about .085 and still under ten cents,
"Mega" sees THIS as a great opportunity. Buy and hold for at least 6 months.
One of our researched articles talks about the bigger players but includes CXY.ax Cougar energy at the bottom of the article.
When you subscribe to Megamoneybox monthly newsletter we will send you a portion of our research on the topic.
Always do your own research on any hot tips. look for CXY.ax Cougar energy - on the Australian stock exchange.
Simply go to http://www.asx.com.au/ type in the code cxy and Cougar Energy page will come up.
Sunday, March 23, 2008
tip for the takers

PRR Prima Biomed looks interesting, Here is what was said about it on the asxinsider forum last august 2007 THE DAY AFTER THE AUGUST 15th 2007 CRASH - or rather CORRECTION!
It always helps to look back at history. His or her story can help you make a better judgement.
We are still holding 5000 purchased at .024cents. (spent approx 500.00- sold some and kept 5000) Currently at .015 so we will wait. We still think that PRR has a future in the battle against ovarian cancer.. also it may take 12 months for it to be accepted on the US drug list. Have a look at the graph above and remember that you can expect to see your stocks fall by as much as 50% regularly. But it still hurts..!! OUCH
go to the asx and put PRR on a watchlist. read their announcements. You can also go to the very quiet http://asxinsider.informe.com/ and see the earlier posts. There you can sign up for free and post your opinion.
Here's an article with some interesting information.
"Thu Aug 16, 2007
abolutely shocking! bottom 2.6 cents Market Pulse: Biotech suffers from another poor day Nick Evans Thursday, 16 August 2007 IT'S been a grim couple of weeks for biotech stocks, as bloodletting on the broader market again impacted on the value of the biotech sector. The benchmark S&P/ASX200 index came down 176.8 points to 5788 and the All Ordinaries finished down 181 points to 5801.5. Eighty-four of BTN's watchlist fell yesterday, 48 by 5% or more. Only 15 gained any ground, and the remainder either did not trade, or remained unchanged. As always, those biotech companies with a positive story to tell fared the best, led by OBJ, the Perth-based drug delivery company which announced that it had scored a major coup by recruiting Dr Ian Frazer to assist with OBJ's drug delivery subsidiary, OBJ Transdermal Vaccines (OBJTV). The company's shares climbed 0.5c to 6c on receipt of the news – gaining around 9% from the announcement. pSivida also had a positive day, as news of the company's positive clinical results from its BrachySil clinical trial finally began to penetrate into the market's thinking, and IMD, Anadis and Genetic Technologies also traded up a little, although all remained within their usual trading range. The big move of the day, however, was Progen, trading back into positive territory after announcing that its liver cancer drug, PI-88, was likely to receive orphan drug status after receiving a positive review by the Committee for Orphan Medical Products (COMP) of the European Agency for the Evaluation of Medicinal Products (EMEA). Progen shares gained 14c for the day, to close at $3.30. Prima BioMed was the biggest loser, shedding 1.5c, or 24%, in late trading to close at 4.7c. Prima almost trebled in value Tuesday, after a minor announcement about an Australian patent grant sparked a frenzy by day traders, who bumped its value from around 1.9c to 6.2c over the course of the day. Prima continued its good run yesterday morning, trading up to 8.7c, a high for the year, until the news that executive director Eugene Kopp had ditched almost his entire holding prompted a scramble for the exit, and the shares plunged back down. Almost 306 million Prima shares changed hands yesterday – including some 16.5 million of Kopp's – which is several times the company's total shares out in the market. KarmelSonix also registered a significant fall, back down to 17c from 20.5c, although the company does appear to have found a new range, having previously traded at around 5–6c before the last month's dramatic rise in value. Metabolic also continued its slump, shedding another 0.5c to close at 5.3c – under half of what it was on Monday, before the company announced that it would be abandoning another drug in Phase 2 trials. Fermiscan also continued its lacklustre recent run, dropping another 27c to close at $1.45. Of the majors, CSL dropped $2.56 to close at $88.50, ResMed lost 21c to close at $4.88, while Cochlear continued to ride positive annual results to record a small increase of 9c to close at $63.34. Most of the late stage small cap companies recorded marginal falls of between 1% and 5%, with the exception of Clinuvel which gained 1c to close at 70c."
"Thu Aug 16, 2007
abolutely shocking! bottom 2.6 cents Market Pulse: Biotech suffers from another poor day Nick Evans Thursday, 16 August 2007 IT'S been a grim couple of weeks for biotech stocks, as bloodletting on the broader market again impacted on the value of the biotech sector. The benchmark S&P/ASX200 index came down 176.8 points to 5788 and the All Ordinaries finished down 181 points to 5801.5. Eighty-four of BTN's watchlist fell yesterday, 48 by 5% or more. Only 15 gained any ground, and the remainder either did not trade, or remained unchanged. As always, those biotech companies with a positive story to tell fared the best, led by OBJ, the Perth-based drug delivery company which announced that it had scored a major coup by recruiting Dr Ian Frazer to assist with OBJ's drug delivery subsidiary, OBJ Transdermal Vaccines (OBJTV). The company's shares climbed 0.5c to 6c on receipt of the news – gaining around 9% from the announcement. pSivida also had a positive day, as news of the company's positive clinical results from its BrachySil clinical trial finally began to penetrate into the market's thinking, and IMD, Anadis and Genetic Technologies also traded up a little, although all remained within their usual trading range. The big move of the day, however, was Progen, trading back into positive territory after announcing that its liver cancer drug, PI-88, was likely to receive orphan drug status after receiving a positive review by the Committee for Orphan Medical Products (COMP) of the European Agency for the Evaluation of Medicinal Products (EMEA). Progen shares gained 14c for the day, to close at $3.30. Prima BioMed was the biggest loser, shedding 1.5c, or 24%, in late trading to close at 4.7c. Prima almost trebled in value Tuesday, after a minor announcement about an Australian patent grant sparked a frenzy by day traders, who bumped its value from around 1.9c to 6.2c over the course of the day. Prima continued its good run yesterday morning, trading up to 8.7c, a high for the year, until the news that executive director Eugene Kopp had ditched almost his entire holding prompted a scramble for the exit, and the shares plunged back down. Almost 306 million Prima shares changed hands yesterday – including some 16.5 million of Kopp's – which is several times the company's total shares out in the market. KarmelSonix also registered a significant fall, back down to 17c from 20.5c, although the company does appear to have found a new range, having previously traded at around 5–6c before the last month's dramatic rise in value. Metabolic also continued its slump, shedding another 0.5c to close at 5.3c – under half of what it was on Monday, before the company announced that it would be abandoning another drug in Phase 2 trials. Fermiscan also continued its lacklustre recent run, dropping another 27c to close at $1.45. Of the majors, CSL dropped $2.56 to close at $88.50, ResMed lost 21c to close at $4.88, while Cochlear continued to ride positive annual results to record a small increase of 9c to close at $63.34. Most of the late stage small cap companies recorded marginal falls of between 1% and 5%, with the exception of Clinuvel which gained 1c to close at 70c."
PRR Prima Biomed had an interesting announcement on 19.03.08.. On page 4 it mentioned apppointment of Dr Ian Frazer as an advisor. This is good news. There may even be a takeover. who knows.
Subscribe to:
Posts (Atom)